Breast cancer outcomes following a national initiative in Ireland to restructure delivery of services for symptomatic disease

Breast

Volumn 17, Issue 4, 2008, Pages 412-417

  de Blacam, Catherine ^a   Gray, Jennifer ^a   Boyle, Terence ^a   Kennedy, M John ^a   Hollywood, Donal ^a   Butt, Javaid ^a   Griffin, Mairead ^a   Nicholson, Siobhan ^a   Dunne, Barbara ^a   Wilson, Graham ^a   McDermott, Ronan ^a   Murphy, Pauline ^a   Short, Ireneus ^a   Rowley, Suzanne ^a   Connolly, Elizabeth ^a   Reynolds, John V ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

Audit; Breast cancer; Multimodal therapy; Outcome

Indexed keywords

ANASTROZOLE; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER STAGING; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HISTOPATHOLOGY; HUMAN; IRELAND; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MEDICAL AUDIT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; SYMPTOMATOLOGY; TREATMENT OUTCOME; WORKSHOP;

EID: 48649106312     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2008.03.011     Document Type: Article

References (27)

1. Campo J, Comber H, Gavin AT. All Ireland cancer statistics 1998-2000: Northern Ireland Cancer Registry/National Cancer Registry; 2004.
2. Development of services for symptomatic breast disease: report of the sub-group to the national cancer forum. Department of Health & Children; 2000.
3. American Joint Committee on Cancer. AJCC cancer staging manual. 6th ed. (2002), Springer, New York, NY
4. Cancer in Ireland 1994-2002. Incidence, mortality, treatment and survival report of National Cancer Registry: Irish National Cancer Registry; 2003.
5. Levi F., Lucchini F., Negri E., Boyle P., and La Vecchia C. Cancer mortality in Europe, 1990-1994, and an overview of trends from 1955 to 1994. European Journal of Cancer 35 10 (1999 Oct) 1477-1516
6. Levi F., Lucchini F., Negri E., and La Vecchia C. The decline in cancer mortality in the European Union, 1988-1996. European Journal of Cancer 36 15 (2000 Oct) 1965-1968
7. Peto R., Boreham J., Clarke M., Davies C., and Beral V. UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet 355 9217 (2000 May 20) 1822
8. Goldhirsch A., Glick J.H., Gelber R.D., and Senn H.J. Meeting highlights: international consensus panel on the treatment of primary breast cancer. Journal of the National Cancer Institute 90 21 (1998 Nov 4) 1601-1608
9. Walsh T.N., and O'Higgins N. Breast cancer management clinical guidelines (2000), Royal College of Surgeons in Ireland
10. Early Breast Cancer Trialists' Collaborative Group. Ovarian ablation in early breast cancer: overview of the randomised trials. Lancet 348 9036 (1996 Nov 2) 1189-1196
11. Howell A., Cuzick J., Baum M., Buzdar A., Dowsett M., Forbes J.F., et al. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet 365 9453 (2005 Jan 1-7) 60-62
12. Thurlimann B., Keshaviah A., Coates A.S., Mouridsen H., Mauriac L., Forbes J.F., et al. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. The New England Journal of Medicine 353 26 (2005 Dec 29) 2747-2757
13. Nabholtz J.M., Reese D.M., Lindsay M.A., and Riva A. HER2-positive breast cancer: update on Breast Cancer International Research Group trials. Clinical Breast Cancer 3 Suppl. 2 (2002 Oct) S75-S79
14. Monnier A.M. The Breast International Group 1-98 trial: big results for women with hormone-sensitive early breast cancer. Expert Review of Anticancer Therapy 7 5 (2007 May) 627-634
15. Poole C. Adjuvant chemotherapy for early-stage breast cancer: the tAnGo trial. Oncology (Williston Park) 18 14 Suppl. 12 (2004 Dec) 23-26
16. Patterns of care and survival or cancer patients in Ireland 1994 to 2001. National Cancer Registry, Ireland; 2006.
17. Sainsbury R., Haward B., Rider L., Johnston C., and Round C. Influence of clinician workload and patterns of treatment on survival from breast cancer. Lancet 345 8960 (1995 May 20) 1265-1270
18. Gilligan M.A., Neuner J., Zhang X., Sparapani R., Laud P.W., and Nattinger A.B. Relationship between number of breast cancer operations performed and 5-year survival after treatment for early-stage breast cancer. American Journal of Public Health 97 3 (2007 Mar) 539-544
19. Gonzalez E.A., Saltzstein E.C., Riedner C.S., and Nelson B.K. Seroma formation following breast cancer surgery. The Breast Journal 9 5 (2003 Sep-Oct) 385-388
20. Wilke L.G., and Giuliano A. Sentinel lymph node biopsy in patients with early-stage breast cancer: status of the National Clinical Trials. The Surgical Clinics of North America 83 4 (2003 Aug) 901-910
21. Mansel R.E., Fallowfield L., Kissin M., Goyal A., Newcombe R.G., Dixon J.M., et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. Journal of the National Cancer Institute 98 9 (2006 May 3) 599-609
22. Sant M., Allemani C., Capocaccia R., Hakulinen T., Aareleid T., Coebergh J.W., et al. Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. International Journal of Cancer 106 3 (2003 Sep 1) 416-422
23. Sant M., Allemani C., Berrino F., Coleman M.P., Aareleid T., Chaplain G., et al. Breast carcinoma survival in Europe and the United States. Cancer 100 4 (2004 Feb 15) 715-722
24. Coleman M.P., Gatta G., Verdecchia A., Esteve J., Sant M., Storm H., et al. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Annals of Oncology 14 Suppl. 5 (2003) v128-v149
25. Cancer services in Ireland: a national strategy. Department of Health & Children; 1996.
26. O'Lorcain P., and Comber H. Mortality predictions for Ireland, 2001-2015: cancers of the breast, ovary, and cervix and corpus uteri. International Journal of Gynecological Cancer 16 Suppl. 1 (2006 Jan-Feb) 1-10
27. Forum TNC. A strategy for cancer control in Ireland. Department of Health & Children; 2006.